|
Market Closed -
Nasdaq
00:00:00 11/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.860 USD | -0.27% |
|
+1.09% | -46.24% |
| 08-24 | Grace Therapeutics Files for Resale of Up to 4.8 Million Shares | MT |
| 08-13 | Grace Therapeutics, Inc. Reports Impairment charges for the First Quarter Ended June 30, 2026 | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| GRCE | Delayed | |
CBOE
| GRCE | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 1.98 | 2.1 | 2.99 |
| Spread/Res. | -6.06% | -11.43% | -37.79% |
| Spread/Supp. | +4.49% | +4.49% | +0.54% |
| Support | 1.78 | 1.78 | 1.85 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- GRCE Stock
- Charts Grace Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
